Anti-Suicide Drugs Market

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.

Anti-Suicide Drugs Market contains market size and forecasts of Anti-Suicide Drugs in global, including the following market information:

Global Anti-Suicide Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-Suicide Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Anti-Suicide Drugs companies in 2021 (%)

The global Anti-Suicide Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-Depressants and Anti-Anxiety Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Suicide Drugs include Pfizer, Inc, AstraZeneca Plc, Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc, H. Lundbeck A/S, NeuroRx, Inc and Johnson & Johnson. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Anti-Suicide Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Suicide Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Suicide Drugs Market Segment Percentages, by Type, 2021 (%)

Anti-Depressants and Anti-Anxiety Drugs

Anti-Psychotic Drugs

NMDA Antagonist

Antibiotic Analog

Global Anti-Suicide Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Suicide Drugs Market Segment Percentages, by Application, 2021 (%)

Hospitals

Retail Pharmacies

Online Pharmacies

Global Anti-Suicide Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Suicide Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Suicide Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-Suicide Drugs revenues share in global market, 2021 (%)

Key companies Anti-Suicide Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Anti-Suicide Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer, Inc

AstraZeneca Plc

Eli Lilly and Company

Allergan Plc

GlaxoSmithKline Plc

Merck & Co., Inc

H. Lundbeck A/S

NeuroRx, Inc

Johnson & Johnson